Serac Healthcare’s Post

View organization page for Serac Healthcare, graphic

205 followers

Continuing positive results from the DETECT study comparing the imaging of superficial peritoneal endometriosis by ⁹⁹ᵐTc-maraciclatide with laparoscopic surgery are being presented today in a poster by one of the investigators, Dr Tatjana Gibbons from the Nuffield Dept of Women's & Reproductive Health, University of Oxford. The poster will be on display at the 7th European Endometriosis Congress taking place in Bucharest from 6-8 June. For full details, please see the press release here https://lnkd.in/eC42HGhV #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine #EEC2024 European Endometriosis League Spectrum Dynamics Medical Hermes Medical Solutions Krina Zondervan Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities.

  • No alternative text description for this image
Anastasia Budinskaya

Investor and biotech community organizer passionate about brain health, women's health, and venture funding for women

2mo

Encouraging to see! Exploratory laparoscopy for endo is a painful experience and anything non-invasive would be a blessing. Looking forward to seeing further results.

Mark Rosser

CEO at Serac Imaging Systems

2mo

Amazing progress, and so far so good!

Like
Reply
Jon Barnett

Head of CMC and Supply Chain at Serac Life Sciences

2mo

Well done to Tatjana and the WRH team

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics